Aker BioMarine: Completion of Sale of Trygg Pharma Holding AS and acquisition of EPAX Holding AS

Reference is made to the stock exchange notice of 3 September 2010 regarding Lindsay Goldberg's acquisition of 50 % of the shares in a newly established joint venture company, Trygg Pharma Holding AS, from Aker BioMarine ASA, the stock exchange notice of 3 September 2010 regarding the purchase by Trygg Pharma AS (a wholly owned subsidiary of Trygg Pharma Holding AS) of 100% of the shares in Epax Holding AS from Austevoll Seafood ASA, and the prospectus dated 29 September 2010 prepared in connection with the rights issue completed in Aker BioMarine ASA, reports www.megafishnet.com with reference to Aker BioMarine.
Lindsay Goldberg's acquisition of 50% of the shares in Trygg Pharma Holding AS from Aker BioMarine ASA and the acquisition by Trygg Pharma AS of 100% of the shares in Epax Holding AS from Austevoll Seafood ASA have been completed in accordance with the agreements entered into between the parties, as further described in the abovementioned stock exchange notices and the prospectus.